This test is recommended for some women with breast cancer that are hormone-receptor positive and node negative. It examines 21 genes to provide a score used to estimate how likely a patient’s cancer is to return. It also shows who can benefit most from chemotherapy in order to prevent the return of the disease, and can therefore help in making treatment decisions. This test is not recommended for everyone so it’s best to consult with your physician.
Posted by